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Nicotinamide	adenine	dinucleotide	 (NAD)	exists	 in	an	oxidized	form	(NAD+) and a re-
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1  | INTRODUC TION
Worldwide,	colorectal	cancer	(CRC)	is	the	third	most	common	cancer	
diagnosed in men and the second most common in women. It also has 
the fourth highest cancer mortality rate in men and the third highest 
in women.1	The	vast	majority	of	CRC	cases	are	 linked	 to	environ-
mental	causes,	such	as	diet,	exercise,	weight,	food-	borne	mutagens,	
specific intestinal commensals and chronic intestinal inflammation.2 
For	example,	patients	with	inflammatory	bowel	disease,	such	as	ul-
cerative	 colitis	 or	Crohn’s	 disease,	 are	 5	 to	7	 times	more	 likely	 to	
develop	CRC.3-6 In addition to cancer cells, tumors are composed 
of various immune and inflammatory cells, including macrophages, 
neutrophils	 and	 T	 lymphocytes.	 These	 cells	 can	 influence	 cancer	
cells via the production of cytokines, chemokines, growth factors 
and	 reactive	 oxygen	 species	 (ROS).7	 ROS	 cause	DNA	damage,	 re-
sulting in an accumulation of gene mutations, and activate specific 
signaling pathways that promote tumor development.8	However,	 if	









that	exists	 in	both	oxidized	 (NAD+)	and	reduced	 (NADH)	forms.	 In	
mammals,	 NAD+	 is	 biosynthesized	 via	 2	 major	 pathways:	 the	 de	
novo and salvage pathways.11	 The	 salvage	 pathway	 is	 important	
for	the	maintenance	of	NAD+ levels in cancer cells and works via 2 
major pathways, one using nicotinamide phosphoribosyltransferase 
(NAMPT)	and	the	other	using	nicotinate	phosphoribosyltransferase	
(NAPRT).	NAMPT	acts	as	a	rate-	limiting	enzyme	in	the	salvage	path-
way and works by transferring a phosphoribosyl group to nicotin-
amide	(NAM)	to	form	nicotinamide	mononucleotide	(NMN).	NMN	is	
then	converted	into	NAD+ by nicotinamide mononucleotide adenyl-
yltransferase	(NMNAT).	NAPRT	is	involved	in	the	synthesis	of	NAD+ 
from nicotinic acid.12	NAMPT	is	upregulated	in	various	cancer	types,	
including prostate, breast, colorectal, gastric and liver cancers,13 and 
could	be	induced	in	response	to	stressors	such	as	genotoxic	stress	






NAD+/NADH	 ratio	 and	 the	NAD(H)	 pool	 size	 can	 regulate	 cancer	
progression and the underlying mechanism.
Because	 NADH	 is	 autofluorescent,	 it	 can	 be	 utilized	 in	 non-	
destructive	optical	imaging	techniques	without	the	use	of	exogenous	
labeling	agents.	 Indeed,	 the	 redox	 ratio,	which	 is	 the	 fluorescence	
intensity	ratio	of	NADH	and	FAD	(NADH/FAD),	 is	commonly	used	




well	 suited	 for	 high-	resolution,	 3-	dimensional,	 non-	invasive	 mea-
surements of deep regions within living tissue.19,20	 The	 detection	
of	 NADH	 by	 TPEF	microscopy	 during	 CRC	 progression	 in	 a	 non-	
invasive manner would be important for developing not only a diag-
nostic	biomarker	but	also	therapeutics	targets	associated	with	NAD+ 
pathways.
In the present study, we investigated the correlation between 
the	NAD(H)	pool	size	and	CRC	progression	and	evaluated	NADH	as	
a	potential	prognostic	marker.	The	NAD(H)	pool	size	was	increased	
during colon cancer progression by activating the salvage pathway 
of	NAD+	synthesis	and	could	protect	tumor	cells	from	excessive	ox-
idative	stress	 induced	by	 inflammation.	NADH	fluorescence	 inten-
sity,	as	measured	by	TPEF	microscopy,	was	consistently	elevated	in	
tumor	 tissues	 from	 CRC	 patients,	 suggesting	 that	 NADH	 fluores-
cence	intensity	could	be	a	biomarker	for	CRC	progression.
2  | MATERIAL S AND METHODS
More	 detailed	 descriptions	 of	 cell	 culture,	 drug	 treatments,	west-









7 days, the mice were administered 2 cycles of 2% DSS (160110, 
MP	Biomedical,	Solon,	OH,	Canada)	for	7	days.	The	mice	were	killed	
60	days	after	the	cessation	of	DSS	treatment.	The	colons	of	those	
mice were dissected longitudinally and washed with PBS immedi-
ately	after	sacrifice.	The	colonic	tissues	were	laid	down	with	the	mu-
cosa	layer	facing	up	on	microscope	slides	for	TPEF	imaging.
2.2 | Reactive oxygen species assay
After	 24	h	 of	 H2O2	 treatment,	 carboxy-	H2DCFDA	 (Invitrogen,	
Carlsbad,	CA,	USA)	was	 added	 to	 each	dish	 at	 a	 concentration	of	
20 μmol/L	for	30	minutes.	The	cells	were	incubated	for	45	minutes	
with medium, and the fluorescence levels were determined using a 
microplate	reader	 (Tecan,	Grödig,	Austria).	To	detect	ROS	levels	 in	
mouse	tissues,	carboxy-	H2DCFDA	(Invitrogen)	was	added	to	colon	
tissues at a concentration of 20 μmol/L	and	 incubated	 for	15	min-
utes.	 The	 tissues	 were	 washed	 with	 PBS.	 The	 fluorescence	 was	





P < .05	was	 considered	 statistically	 significant.	 All	 samples	 except	
for	animal	samples	were	prepared	in	triplicate	for	every	experiment.	
The	data	represent	at	least	3	independent	experiments	and	are	pre-
sented as the mean ± SD.
2.4 | Study approval
Human	 colon	 cancer	 specimens	 and	 their	 paired	 normal	 speci-
mens	were	obtained	from	Asan	Bio-	Resource	Center.	All	processes	
were	 performed	 under	 the	 approval	 of	 the	 Asan	Medical	 Center	
Institutional	Review	Board.	All	animal	experiments	were	performed	
in accordance with the guidelines and regulations and with the ap-
proval	 of	 The	 Institutional	 Animal	 Care	 and	 Use	 Committees	 at	
POSTECH.
3  | RESULTS
3.1 | The NAD(H) pool size could increase in 
malignant colorectal cancer cell lines resulting from 
activation of the salvage pathway of NAD+ synthesis
As	 cancer	 cells	 require	 the	 rapid	 turnover	 of	NAD+,12 we investi-
gated	 the	 correlation	of	NAD(H)	pool	 size	 and	NAD+/NADH	 ratio	
with	 colon	 cancer	 progression.	We	measured	 each	 level	 of	NAD+	
and	NADH	in	normal	gut	epithelial	CCD-	18Co	cells	and	in	CRC	cell	
lines,	including	the	SW480,	RKO	and	HCT116	cell	lines	by	enzymatic	
method.	We	obtained	NAD(H)	pool	 size	by	adding	 levels	of	NAD+ 








(n = 9). *P	<	.05	by	Student’s	t test




In	 addition,	 NADH	 fluorescence	 detected	 using	 TPEF	microscope	
at	a	740-	nm	wavelength	was	consistently	stronger	 in	the	CRC	cell	
lines	 than	 in	 the	normal	 gut	 epithelial	 cells,	 InEpC	and	CCD-	18Co	
cells	(Figure	1E).	Therefore,	CRC	cells	were	found	to	maintain	a	large	
NAD(H)	pool	size	and	a	high	NAD+/NADH	ratio.
To	 identify	 which	 factors	 could	 increase	 the	 NAD(H)	 pool	







NADH	 (Figure	1F-	I),	 suggesting	 that	 activation	 of	 the	 salvage	
pathway	could	increase	both	the	NAD(H)	pool	size	and	the	NAD+/
NADH	ratio	in	CRC	cells.
3.2 | NADH fluorescence reflects the NAD(H) 
pool size
We	 next	 examined	 whether	 inhibition	 of	 the	 enzymes	 NAMPT,	
NAPRT	 and	 NMNAT1	 could	 decrease	 NAD+	 and	 NADH	 levels.	
Knockdown	 of	 NAPRT	 or	 NMNAT1	 barely	 reduced	 the	 NAD+ 
and	 NADH	 levels,	 whereas	 knockdown	 of	 NAMPT	 significantly	
decreased	both	the	NAD+	(Figure	2A)	and	NADH	(Figure	2B)	lev-









bars represent the mean ± SD (n = 9). *P	<	.05	by	Student’s	t test
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Moreover,	 NMN	 treatment	 restored	 the	 levels	 of	 NAD+, and 
NADH	and	increased	the	NAD(H)	pool	and	NAD+/NADH	ratio	in	
NAMPT-	knockdown	 cells	 (Figure	2E-	H),	 indicating	 that	 NAMPT	
could	not	only	 critically	 determine	 the	NAD+ levels but also the 
NAD(H)	pool	size.
Nicotinamide	 phosphoribosyltransferase	 inhibition	 through	
treatment	with	 FK866	 for	 12	hours	 slightly	 decreased	 the	NAD+/











cific	 to	 glucose-	6-	phosphate	 dehydrogenase	 (G6PD),	 an	 enzyme	
that	 is	critical	 for	NADPH	production	 (Figure	S1E).	G6PD	knock-
down	 specifically	 downregulated	 NADPH	 levels	 (Figure	 S1A-	D)	 







quantified	in	normal	colon	tissue	and	AOM/DSS-	induced	CRC	tissue.	The	bars	represent	the	mean	±	SD	(n	=	5).	*P	<	.05	by	Student’s	t test. I, 
NADH	and	FAD	fluorescence	levels	were	detected	in	normal	colon	tissue	and	AOM/DSS-	induced	CRC	tissue	at	the	indicated	depths	of	20,	
40 and 60 μm (scale bar, 100 μm).	J,	NADH	fluorescence	intensity	at	the	indicated	depth	was	quantified.	*P	<	.05	by	Student’s	t	test.	K,	The	
NADH/FAD	ratios	in	normal	tissue	and	AOM/DSS-	induced	CRC	tissue	were	quantified	at	the	indicated	depths	using	the	MATLAB	program
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NAMPT	 knockdown	 led	 to	 a	 decrease	 in	 fluorescence	 intensity	
(Figure	S1F,G).	This	 result	was	 likely	because	2-	fold	more	NADH	
was	present	than	NADPH	(Figure	S1B,D).	Our	observations	 indi-
cated	 that	NAMPT	 could	 regulate	 the	NAD(H)	 pool	 size	 by	me-
diating	NAD+	 influx	and	that	the	fluorescence	intensity	detected	
by	 TPEF	 microscopy	 at	 a	 740-	nm	 wavelength	 could	 reflect	 the	
NAMPT-	mediated	regulation	of	the	NAD(H)	pool	size.
3.3 | The NAD(H) pool increases in azoxymethane/






regimen	developed	CRC	(Figure	3B,C).	The	NAD+ salvage pathway 
was	 consistently	 activated	 in	 the	AOM/DSS	mice,	 as	 indicated	by	




sues, including colon cancer cells and immune cells. F4/80, a mac-
rophage	marker,	 and	CD3,	 a	 T	 cell	marker,	were	 also	 increased	 in	
AOM/DSS-	induced	 CRC	 tissues	 and	 co-	localized	 with	 NAMPT	
(Figure	S2).	Next,	we	compared	the	NAD(H)	pool	size	between	the	
normal	 gut	 epithelium	 and	 AOM/DSS-	induced	 tumor	 tissue.	 Both	
















were treated with 800 μmol/L	H2O2	or	1	mmol/L	NAC	for	24	h.	Cell	death	was	assessed	by	trypan	blue	staining.	G,	RKO	cells	were	treated	
with 800 μmol/L	H2O2	for	12	h.	ROS	measurements	were	performed	using	carboxy-	H2DCFDA.	The	bars	represent	the	mean	±	SD	(n	=	9).	
*P	<	0.05	by	Student’s	t test. a.u., arbitrary unit




3.4 | Increases in the NAS(H) pool by nicotinamide 
phosphoribosyltransferase protect cancer cells 
against detrimental oxidative stress
Azoxymethane/dextran	sodium	sulfate	mice	have	been	widely	uti-
lized	to	examine	the	role	of	inflammation	in	colon	carcinogenesis	
and	 the	 contribution	 of	 inflammation-	induced	 ROS	 production	
to	CRC	progression.21	Because	NAMPT	has	been	reported	to	 in-
crease	 the	antioxidant	capacity	of	 tumor	cells,15 we investigated 




exhibited	 low	 levels	 of	 ROS	 relative	 to	 the	 surrounding	 regions	
with	low	levels	of	NADH	(Figure	4A).	To	confirm	that	ROS	produc-
tion was increased by inflammatory cytokines and immune cells in 
AOM/DSS	mice,	we	detected	 IFN-	γ and the macrophage marker 
F4/80	 by	 IHC	 experiments.	 Both	 proteins	 were	 expressed	 at	
higher	levels	in	CRC	tissues	than	in	normal	gut	tissues	(Figure	4B).	
These	 results	 indicate	 that	 the	 ROS	 level	 was	 increased	 by	 in-
flammation	 in	AOM/DSS	mice	 and	was	 downregulated	 in	 tumor	
regions	with	 large	NAD(H)	 pools.	 Our	 findings	 suggest	 that	 the	
increase	in	NAD(H)	pools	in	tumor	tissues	could	reduce	the	detri-
mental	oxidative	stress	induced	by	inflammation.
Next,	 we	 investigated	 whether	 decreasing	 the	 excessive	 ROS	
levels	 by	 increasing	 the	NADH	pool	 size	would	 promote	CRC	 cell	
survival.	 We	 found	 that	 exogenous	 H2O2 treatment increased 
NAMPT	 expression	 by	 approximately	 3-	fold	 in	 CRC	 cell	 lines	 and	
produced	only	marginal	changes	in	normal	gut	epithelial	CCD-	18Co	
cells	(Figure	4C,D).	Moreover,	NAMPT	knockdown	and	FK866	treat-
ment	 dramatically	 increased	 CRC	 cell	 death	 and	 ROS	 levels	 upon	
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NAD+	 or	NAC	 (Figure	4E-	G).	 Collectively,	 these	 findings	 indicated	
that	upregulation	of	NAMPT	by	inflammation-	induced	ROS	produc-
tion	 protected	 tumor	 cells	 against	 excessive	 oxidative	 stress	 and	
promoted	CRC	progression.
3.5 | FK866 inhibits colorectal cancer progression in 
azoxymethane/dextran sodium sulfate mice
To	 investigate	 whether	 NAMPT	 inhibition	 could	 suppress	 CRC	








data	 indicated	that	FK866	could	 inhibit	CRC	progression	 in	AOM/
DSS	mice	by	causing	excessive	accumulation	of	ROS.






S1).	 Similar	 to	 AOM/DSS	 mice,	 the	 NADH	 fluorescence	 intensity	
was	significantly	stronger	in	tumor	tissue	than	in	non-	tumor	tissue	
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4  | DISCUSSION
Cancer	cells	require	significantly	more	NAD+ than normal cells due 
to	their	elevated	metabolic	needs.	The	cytosolic	NAD+/NADH	ratio	
was	 reported	 to	 downregulate	 in	 cancer	 cell	 lines	 such	 as	H1299,	
U87	and	MDA-	MB468,	as	observed	by	genetically	engineered	fluo-
rescent	 biosensors	 that	 can	 measure	 protein-	unbound	 species	 of	
NAD(H).22,23	In	this	study,	we	quantified	the	total	NAD(H)	levels	in	
whole	cell	lysates	by	enzymatic	assays.	Both	the	NAD+/NADH	ratio	
and	 NAD(H)	 pool	 size	 were	 increased	 according	 to	 colon	 cancer	
progression	in	response	to	enhanced	NAD+	influx	due	to	upregula-
tion	of	 enzymes	 in	NAD+	 salvage	 synthesis.	 In	 particular,	NAMPT	
was	 critical	 to	 maintain	 the	 NAD(H)	 pool	 size	 and	 NAD+/NADH	
ratio (Figure 2) and was also upregulated in colon cancer tissues 
of	 patients	 (Figure	6).	 Consistently,	 NAMPT	 expression	 was	 cor-
related with colon cancer patient outcome regardless of the tumor 
staging	and	 induced	cancer	stem-	like	properties	 in	colon	cancer.24 
Furthermore,	 reduction	 of	 the	 NAD(H)	 pool	 by	 FK866	 treatment	
effectively	 inhibited	 AOM/DSS-	induced	 colon	 cancer	 (Figure	5),	
supporting	 that	NAMPT-	mediated	NAD(H)	pool	 increase	 could	be	
critical to colon cancer progression. In contrast, suppression of de 
novo	 NAD+	 synthesis	 by	 unconventional	 pre-	fold	 in	 RPB5	 inter-
actor	 (URI)	 expression	 is	 known	 to	 promote	 liver	 tumorigenesis	
in	 a	 diethylnitrosamine-	induced	 hepatocellular	 carcinoma	 mouse	
model.25	Therefore,	 it	would	be	worthwhile	 to	 further	 investigate	
whether	inhibition	of	salvage	NAD+	synthesis	by	NAMPT	knockout	
could affect cancer progression in a mouse model.













cellular	NADH	as	a	 result	of	 the	different	cofactors	bound	by	 the	













pending on the cell and tissue types, the location of ROS produc-
tion,	the	individual	ROS	levels	and	the	antioxidant	capacity	of	cancer	
cells.28	Cancer	cells	 that	 survive	despite	oxidative	 stress	are	 likely	
to	have	acquired	adaptive	mechanisms	to	counteract	the	potential	




duced	by	H2O2 treatment in normal cells, but it was dramatically in-
creased	in	CRC	cells	(Figure	4C),	indicating	that	NAMPT	expression	




creased ROS levels relative to surrounding tissues with low levels 





Interestingly,	 NAMPT	was	 upregulated	 in	 both	 cancer	 and	 in-
flammatory	 immune	 cells	 (Figure	 S2).	 A	 previous	 report	 revealed	
that	 immune	 cells	 recruited	 into	DSS-	induced	 colitis	 tissues,	 such	
as	macrophages,	 dendritic	 cells,	 T	 cells	 and	natural	 killer	 cells,	 ex-
hibited	upregulated	NAMPT	expression,	and	FK866	treatment	de-
creased inflammatory responses.16	 Consistently,	 the	 IFN-	γ levels 
were	reduced	in	FK866-	treated	AOM/DSS	tissues	(Figure	S4).	Taken	
together,	 the	 increases	 in	 the	 NAD(H)	 pool	 mediated	 by	 NAMPT	
could	suppress	excessive	oxidative	stress-	induced	cell	death	in	can-
cer cells and promote inflammatory cytokine production in immune 
cells,	leading	to	inflammation-	induced	CRC	progression.	Therefore,	
FK866 treatment increased detrimental ROS levels in cancer cells 
and decreased inflammatory cytokine levels in immune cells, inhibit-
ing colon cancer progression.
In conclusion, we investigated the correlation between the 





induced	 CRC	 progression	 by	 decreasing	 the	 detrimental	 effects	
associated	with	excessive	ROS	accumulation.	Furthermore,	NADH	
might	 serve	 as	 a	 useful	 non-	invasive	marker	with	 intrinsic	 auto-
fluorescence properties because its levels could represent the 
NAD(H)	pool	size.	Based	on	our	findings,	the	non-	invasive	detec-
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